Intra Cellular Therapies reported $0 in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 4.17M 125.57M
ALKERMES ALKS:US $ 297.07M 0.63M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 43.5M 1.09M
Biocryst Pharmaceuticals BCRX:US $ 293.66M 9.32M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Cytokinetics CYTK:US $ 139.14M 1.75M
Esperion Therapeutics ESPR:US $ 272.1M 404K
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Halozyme Therapeutics HALO:US $ 874.74M 0.96M
Intra Cellular Therapies ITCI:US $ 0M 0M
JAZZ PHA JAZZ:US $ 6744.3M 4642.65M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Novartis NVS:US $ 35769M 2030M
Prothena PRTA:US $ 0M 0M
Redhill Biopharma RDHL:US $ 87.83M 0.28M
Supernus Pharmaceuticals SUPN:US $ 370.38M 18.83M
United Therapeutics UTHR:US $ 800M 0M
Vanda Pharmaceuticals VNDA:US $ 0M 0M
Zogenix ZGNX:US $ 153.63M 2.18M